Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data

This retrospective single-center study analyzes the efficacy and safety of isotretinoin for the treatment of moderate to severe acne in real-life clinical practice, particularly with regard to acne severity, isotretinoin cumulative dosage, and patients’ gender. The results suggest the opportunity of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nevena Skroza, Ersilia Tolino, Veronica Balduzzi, Nicoletta Bernardini, Alessandra Mambrin, Anna Marchesiello, Federica Marraffa, Giovanni Rossi, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/f9468292f7484ade8b7255433d01633b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f9468292f7484ade8b7255433d01633b
record_format dspace
spelling oai:doaj.org-article:f9468292f7484ade8b7255433d01633b2021-11-12T04:43:12ZAdvantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data1663-981210.3389/fphar.2021.733526https://doaj.org/article/f9468292f7484ade8b7255433d01633b2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.733526/fullhttps://doaj.org/toc/1663-9812This retrospective single-center study analyzes the efficacy and safety of isotretinoin for the treatment of moderate to severe acne in real-life clinical practice, particularly with regard to acne severity, isotretinoin cumulative dosage, and patients’ gender. The results suggest the opportunity of an early isotretinoin systemic treatment in patients affected by moderate acne and emphasize the importance of an appropriate dose adjustment in order to minimize adverse events.Nevena SkrozaErsilia TolinoVeronica BalduzziNicoletta BernardiniAlessandra MambrinAnna MarchesielloFederica MarraffaGiovanni RossiSalvatore VolpeIlaria ProiettiConcetta PotenzaFrontiers Media S.A.articleisotretinoinefficacysafetyacne severitygenderTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic isotretinoin
efficacy
safety
acne severity
gender
Therapeutics. Pharmacology
RM1-950
spellingShingle isotretinoin
efficacy
safety
acne severity
gender
Therapeutics. Pharmacology
RM1-950
Nevena Skroza
Ersilia Tolino
Veronica Balduzzi
Nicoletta Bernardini
Alessandra Mambrin
Anna Marchesiello
Federica Marraffa
Giovanni Rossi
Salvatore Volpe
Ilaria Proietti
Concetta Potenza
Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
description This retrospective single-center study analyzes the efficacy and safety of isotretinoin for the treatment of moderate to severe acne in real-life clinical practice, particularly with regard to acne severity, isotretinoin cumulative dosage, and patients’ gender. The results suggest the opportunity of an early isotretinoin systemic treatment in patients affected by moderate acne and emphasize the importance of an appropriate dose adjustment in order to minimize adverse events.
format article
author Nevena Skroza
Ersilia Tolino
Veronica Balduzzi
Nicoletta Bernardini
Alessandra Mambrin
Anna Marchesiello
Federica Marraffa
Giovanni Rossi
Salvatore Volpe
Ilaria Proietti
Concetta Potenza
author_facet Nevena Skroza
Ersilia Tolino
Veronica Balduzzi
Nicoletta Bernardini
Alessandra Mambrin
Anna Marchesiello
Federica Marraffa
Giovanni Rossi
Salvatore Volpe
Ilaria Proietti
Concetta Potenza
author_sort Nevena Skroza
title Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
title_short Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
title_full Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
title_fullStr Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
title_full_unstemmed Advantages of Tailored Isotretinoin Treatment in Moderate to Severe Acne: Real-Life Data
title_sort advantages of tailored isotretinoin treatment in moderate to severe acne: real-life data
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f9468292f7484ade8b7255433d01633b
work_keys_str_mv AT nevenaskroza advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT ersiliatolino advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT veronicabalduzzi advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT nicolettabernardini advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT alessandramambrin advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT annamarchesiello advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT federicamarraffa advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT giovannirossi advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT salvatorevolpe advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT ilariaproietti advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
AT concettapotenza advantagesoftailoredisotretinointreatmentinmoderatetosevereacnereallifedata
_version_ 1718431265508556800